email   Email Us: info@lupinepublishers.com phone   Call Us: +1 (914) 407-6109   57 West 57th Street, 3rd floor, New York - NY 10019, USA

Lupine Publishers Group

Lupine Publishers

  Submit Manuscript

ISSN: 2637-4609

Archives of Organic and Inorganic Chemical Sciences

Review Article(ISSN: 2637-4609)

Molar characterization and analytical UPLC method development of matrix impurity, disregards impurity, specified impurity associated undetectable impurity of laboratory drug Isatin

Volume 3 - Issue 4

Rahul Hajare*

  • Author Information Open or Close
    • Department of Health Research, Ministry of Health and Family Welfare, New Delhi, India

    *Corresponding author: Rahul Hajare, Department of Health Research, Ministry of Health and Family Welfare, New Delhi, India

Received: June 23, 2018;   Published: August 01, 2018

DOI: 10.32474/AOICS.2018.03.000166

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

This is out line work on the process development for the impurity detection of Isatin from synthetic occurring and several new methods have been developed during the pursuit of this research. The article traces the evolution of various approaches and provides a comparison for overall efficiency. UPLC method has been developed and validated for simultaneous estimation of matrix impurity, disregards impurity; specified impurity associated undetectable impurity in pure synthetic formulations. Separation was carried out using column Hypersil ODS C18 (250 mm x 4.6mm x 5μm particle size) in isocratic mode using mobile phase composition pH 6.0 ammonium acetate Buffer: Acetonitrile (68:32) v/v and UV detection at 310 nm. The impurities were eluted at a flow rate of 1.0 mL/ min. The average retention times for matrix impurity, disregards impurity, specified impurity associated undetectable impurity were 2.86 and 3.67 min, 4.54 min respectively. The method was validated according to the ICH guidelines.

Keywords: Matrix Impurity; Disregards Impurity; Specified Impurity Associated Undetectable Impurity; UPLC; Ich Guidelines; Process Development

Abstract| Introduction| Assay Liquid chromatography (2.2.29 European Pharmacopiea 5.0) as described in the test for related substances with the following modifications| Limits| Acknowledgement| References|

https://www.high-endrolex.com/21